Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: Effects on 15-F2t-isoprostane formation

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 1, 2003, Pages 14-21

  Xia, Zhengyuan ^a   Godin, David V ^a   Chang, Thomas K H ^a   Ansley, David M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Department of Anesthesia ^*  (Canada)

Author keywords

15 F2t isoprostane; Ischemia reperfusion; Myocardium; Propofol

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; PROPOFOL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG ACTIVITY; HEART FUNCTION; HEART PERFUSION; HEART PROTECTION; ISCHEMIA; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ANESTHETICS, INTRAVENOUS; ANIMALS; ANTIOXIDANTS; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; F2-ISOPROSTANES; HEART; LIPID PEROXIDATION; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT;

EID: 0037247879     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-170     Document Type: Article

References (24)

1. Ambrosio, G., and Tritto, I. 1999. Reperfusion injury: experimental evidence and clinical implications. Am. Heart. J. 138: S69-S75.
2. Ansley, D.M., Sun, J., Visser, W.A., Dolman, J., Godin, D.V., Garnett, M.E., and Qayumi, A.K. 1999. High dose propofol enhances red cell antioxidant capacity during CPB in humans. Can. J. Anaesth. 46: 641-648.
3. Awad, J.A., Morrow, J.D., Hill, K.E., Roberts, L.J., 2nd, and Burk, R.F. 1994. Detection and localization of lipid peroxidation in selenium and vitamin E-deficient rats using F2-isoprostanes. J. Nutr. 124: 810-816.
4. Bolli, R. 1991. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc. Drugs Ther. 5: 249-268.
5. Chiabrando, C., Avanzini, F., Rivalta, C., Colombo, F., Fanelli, R., Palumbo, G., and Roncaglioni, M. 2002. Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors. Curr. Control. Trials Cardiovasc. Med. 3: 5.
6. Hearse, D.J., and Bolli, R. 1992. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc. Res. 26: 101-108.
7. Hearse, D.J., and Sutherland, F.J. 1999. Catecholamines and preconditioning: studies of contraction and function in isolated rat hearts. Am. J. Physiol. 277: H136-H143.
8. Hamilton, D.L., Boyett, M.R., Harrison, S.M., Davies, L.A., and Hopkins, P.M. 2000. The concentration-dependent effects of propofol on rat ventricular myocytes. Anesth. Analg. 91: 276-282.
9. Ko, S.H., Yu, C.W., Lee, S.K., Choe, H., Chung, M.J., Kwak, Y.G., Chae, S.W., and Song, H.S. 1997. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth. Analg. 85: 719-724.
10. Kokita, N., Hara, A., Abiko, Y., Arakawa, J., Hashizume, H., and Namiki, A. 1998. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth. Analg. 86: 252-258.
11. Kromer, B.M., and Tippins, J.R. 1999. The vasoconstrictor effect of 8-epi prostaglandin F2α in the hypoxic rat heart. Br. J. Pharmacol. 126: 1171-1174.
12. ATP channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Anesthesiology, 91: 1349-1360.
13. Mobert, J., Becker, B.F., Zahler, S., and Gerlach, E. 1997. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2α and E2) in isolated guinea pig hearts. J. Cardiovasc. Pharmacol. 29: 789-794.
14. Morrow, J.D., and Roberts, L.J., 2nd. 1994. Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol. 233: 163-174.
15. Morrow, J.D., and Roberts, L.J. 1997. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36: 1-21.
16. Palmer, A.M., Thomas, C.R., Gopaul, N., Dhir, S., Anggard, E.E., Poston, L., and Tribe, R.M. 1998. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia, 41: 148-156.
17. Roberts, L.J., 2nd, and Morrow, J.D. 1999. The generation and actions of isoprostanes. Biochim. Biophys. Acta, 1345: 121-125.
18. Runzer, T.D., Ansley, D.M., Godin, D.V., and Chambers, G.K. 2002. Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model. Anesth. Analg. 94: 89-93.
19. Taber, D.F., Morrow, J.D., and Roberts, L.J., 2nd. 1997. A nomenclature system for the isoprostanes. Prostaglandins, 53: 63-67.
20. Tamaki, F., Oguchi, T., Kashimoto, S., Nonaka, A., and Kumazawa, T. 2001. Effects of propofol on ischemia and reperfusion in the isolated rat heart compared with thiamylal. Jpn. Heart J. 42: 193-206.
21. Toufektsian, M.C., Boucher, F.R., Tanguy, S., Morel, S., and de Leiris, J.G. 2001. Cardiac toxicity of singlet oxygen: implication in reperfusion injury. Antioxid. Redox Signal. 3: 63-69.
22. van Amsterdam, F.T., Punt, N.C., Haas, M., van Amsterdam-Magnoni, M.S., and Zaagsma, J. 1989. Stereoisomers of BAY K 8644 show opposite activities in the normal and ischaemic rat heart. A comparison with nifedipine. Naunyn Schmiedebergs Arch. Pharmacol. 339: 647-652.
23. Wagner, F.M., Weber, A.T., Ploetze, K., Schubert, F., Pfeiffer, S., Albrecht, S., and Schueler, S. 2002. Do vitamins C and E attenuate the effects of reactive oxygen species during pulmonary reperfusion and thereby prevent injury? Ann. Thorac, Surg. 74: 811-817.
24. Westhuyzen, J., Cochrane, A.D., Tesar, P.J., Mau, T., Cross, D.B., Frenneaux, M.P., Khafagi, F.A., and Fleming, S.J. 1997. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. J. Thorac. Cardiovasc. Surg. 113: 942-948.